Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	312.48	59.02	14.31
Graham Fair Price	-89.37	1.63	15.32
PEG	9393.17	-5.14	0.05
Price/Book	-18.55	1.26	1.54
Price/Cash Flow	311.26	-39.86	9.69
Prices/Earnings	7103.97	507.83	7.05
Price/Sales	88.45	2.14	1.13
Price/FCF	311.26	-39.86	9.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.46	0.26	0.27
Operating Margin	-80.10	0.01	0.06
ROA	-98.84	< 0.005	0.03
ROE	0.05	< 0.005	-98.87
ROIC	0.04	< 0.005	-91.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.14	0.08	75.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.95	-0.91	-3.96
EPS QOQ	1.30	-0.99	-24.11
FCF QOQ	2.66	-1.20	-55.02
Revenue QOQ	0.94	-0.57	-39.67
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.10	99.96	131.91
Days Sales Outstanding (DSO)	21.70	48.79	124.90
Inventory Turnover	2.09	0.90	-56.88
Debt/Capitalization	0.30	0.28	-6.54
Quick Ratio	1.33	1.22	-7.92
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.82	13.82	< 0.005
Cash	3.39	2.76	-18.55
Capex	-0.23	-0.06	72.35
Free Cash Flow	2.20	-0.44	-80.19
Revenue	18.77	8.11	-56.78
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.47	2.45	-0.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.76	8.36	374.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating